(Q38204104)

31 August 2017

title

Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

31 August 2017

0 references

0 references

author

Fernando Magro

7

1 reference

31 August 2017

8

Iris Dotan

1 reference

31 August 2017

Florian Rieder

1

1 reference

31 August 2017

Jessica R de Bruyn

2

1 reference

31 August 2017

Bao Tung Pham

3

1 reference

31 August 2017

Konstantinos Katsanos

4

1 reference

31 August 2017

Vito Annese

5

1 reference

31 August 2017

Peter D R Higgins

6

1 reference

31 August 2017

publication date

13 April 2014

1 reference

Journal of Crohn's and Colitis

31 August 2017

published in

1 reference

31 August 2017

volume

8

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

1166-1178

1 reference

Long-term evolution of disease behavior of Crohn's disease

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Benign and malignant colorectal strictures in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

The gut microbiome in intestinal fibrosis: environmental protector or provocateur?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Genetic risk profiling and prediction of disease course in Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Predictors of fibrostenotic Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Serum laminin and collagen IV in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Plasma fibronectin in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Noninvasive methods to assess liver disease in patients with hepatitis B or C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Non-invasive evaluation of liver fibrosis using transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Assessment of hepatic fibrosis with magnetic resonance elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Idiopathic pulmonary fibrosis: the need for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Peripheral blood biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

The role of radiology in the management of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Application of biomarkers to clinical trials in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Biomarkers for skin involvement and fibrotic activity in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Accurate measurement and clinical significance of urinary transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Resistive index predicts renal prognosis in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Optimized pregelatinized starch technique for cell block preparation in cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Multiplexed salivary protein profiling for patients with respiratory diseases using fiber-optic bundles and fluorescent antibody-based microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

The connective tissue changes of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Neuromuscular and vascular hamartoma of the small intestine: is it Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Role of Magnetic Resonance Enterography in Differentiating between Fibrotic and Active Inflammatory Small Bowel Stenosis in Patients with Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Quantitative contrast-enhanced ultrasound comparison between inflammatory and fibrotic lesions in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Non-invasive monitoring of tissue scaffold degradation using ultrasound elasticity imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Noninvasive ultrasound elasticity imaging (UEI) of Crohn's disease: animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

What determines the natural history of recurrent hepatitis C after liver transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

Osteopontin in the development of systemic sclerosis--relation to disease activity and organ manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.009

10.1016/J.CROHNS.2014.03.009

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference